This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acute and Chronic Non-radicular LBP
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Patients with acute or chronic Lower Back Pain (LBP) participated in a Phase IV clinical trial to assess the effectiveness of Lidoderm administered once daily (q24h) for 2 weeks in the treatment of acute and chronic LBP.

Provided treatments

  • Drug: Lidoderm®
Tris trial is registered with FDA with number: NCT00904540. The sponsor of the trial is Endo Pharmaceuticals and it is looking for 131 volunteers for the current phase.
Official trial title:
Open-Label Study Assessing the Efficacy of Topical Lidocaine Patch in Treatment of Low Back Pain